Skip to main content

Table 3 Clinical characteristics of patients treated with PLD for lymphoma

From: High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study

Clinical characteristics   Number of cases (Percentage)
Gender Male 72(43.1%)
Female 95(56.9%)
Age ≤60 73(43.7%)
> 60 94(56.3%)
Clinical stage I-II 77(46.1%)
III-IV 90(53.9%)
ECOG score < 2 108(64.7%)
≥2 59(35.3%)
IPI score 1–2 94(56.3%)
3–5 73(43.7%)
Whether there are large tumor masses Yes 28(16.8%)
No 139(83.2%)
Pathological type HL 24(14.4%)
NHL 143(85.6%)
Group B symptoms Yes 64(38.3%)
No 103(61.7%)
LDH Normal 65(38.9%)
Elevated 102(61.1%)
History of gallstones Yes 11(6.6%)
No 156(93.4%)
Viral hepatitis Yes 23(13.8%)
No 144(86.2%)
  1. *Abbreviations: IPI International Prognostic Index, LDH lactate dehydrogenase